Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-28

FDA Approved: VEVYE — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved a supplemental application for VEVYE (cyclosporine ophthalmic solution) from Harrow Eye, LLC. The approval pertains to the ophthalmic cyclosporine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)

Snippet

SUPPL AP for VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)